Clinical Trials Browser

Endometrial Adenocarcinoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Stomach Neoplasms, Gastrointestinal Stromal Tumors

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Osteosarcoma, Histiocytoma, Malignant Fibrous

Brain Neoplasms, Glioblastoma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Oligodendroglioma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Glioblastoma, Glioma, Gliosarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neuroepithelial, Gliosarcoma

Glioblastoma, Glioma, Gliosarcoma

Carcinoid Tumor, Carcinoma, Non-Small-Cell Lung, Lymphoma, Neoplasm Metastasis, Sarcoma, Colorectal Neoplasms

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Neuroblastoma, Sarcoma, Sarcoma, Ewing

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Glioblastoma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Sarcoma, Neurofibrosarcoma

Glioblastoma, Glioma, Gliosarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Sarcoma, Kaposi

Hemangiosarcoma, Sarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Hemangiosarcoma, Sarcoma

Gastrointestinal Stromal Tumors

Neoplasms, Sarcoma, Kaposi, HIV Infections

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Histiocytoma, Benign Fibrous

Rhabdomyosarcoma, Sarcoma

Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Histiocytoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Gliosarcoma

Glioblastoma, Glioma, Recurrence, Gliosarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Sarcoma, Kaposi

Glioblastoma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Glioblastoma, Glioma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Glioblastoma, Glioma, Gliosarcoma

Clinical Trials

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors

Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab

Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma

Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma

Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

BBP

Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Bevacizumab in Treating Patients With Recurrent or Progressive Glioma

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma

Bevacizumab in Treating Patients With Angiosarcoma

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

S0502

Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients

Bevacizumab and Radiation Therapy for Sarcomas

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma

AMG 102 and Avastin for Recurrent Malignant Glioma

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity

Phase II Study of Doxorubicin and Avastin® in Sarcoma.

AVF4120s

Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas

Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme

Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma

Ph II Bevacizumab + Etoposide for Pts w Recurrent MG

Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan

Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas

Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)

A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)